Finnadvance is a startup based in Finland, 3 tracked investors.
Finnadvance is a company headquartered in Finland. Brouky records 3 investors associated with the company.
Finnadvance develops multi-channel 3D microfluidic organ-on-chip devices and platforms used by pharmaceutical companies and research organizations to model human organs for preclinical drug discovery and reduce reliance on animal testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.